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Abstract  
Background: Lower risk of breast cancer has been reported among physically active women, 
but the risk in women using hormone replacement therapy (HRT) appears to be higher. We 
quantified the association between physical activity and breast cancer, and we examined the 
influence that HRT use and other risk factors had on this association. 
Methods: After a systematic literature search, prospective studies were meta-analysed using 
random-effect models applied on highest vs. lowest level of physical activity. Dose-response 
analyses were conducted with studies reporting physical activity either in hours/week or in 
hours of metabolic equivalent per week (MET-h/week).  
Results: The literature search identified 38 independent prospective studies published 
between 1987 and 2014 that included 116,304 breast cancer cases. Compared to the lowest 
level of physical activity, the highest level was associated with a summary relative risk (SRR) 
of 0.88 (95% CI (0.85, 0.90)) for all breast cancer, 0.89 (95%CI (0.83, 0.95)) for ER+/PR+ 
breast cancer and 0.80 (95%CI (0.69, 0.92)) for ER-/PR- breast cancer. Risk reductions were 
not influenced by the type of physical activity (occupational or non-occupational), adiposity, 
and menopausal status. Risk reductions increased with increasing amounts of physical 
activity, without threshold effect. In six studies, the SRR was 0.78 (95% CI (0.70, 0.87)) in 
women who never used HRT and 0.97 (95% CI (0.88, 1.07)) in women who ever used HRT, 
without heterogeneity in results.  Findings indicate that a physically inactive women engaging 
in at least 150 minutes per week of vigorous physical activity would reduce their lifetime risk 
of breast cancer by 9%, a reduction that might be two times greater in women who never used 
HRT. Conclusion: Increasing physical activity is associated with meaningful reductions in 
the risk of breast cancer, but in women who ever used HRT, the preventative effect of 
physical activity seems to be cancelled out.  
Keywords: physical activity; prospective studies; breast cancer; HRT; meta-analysis. 
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Introduction 
Breast cancer is the commonest incident form of cancer in women worldwide which is 
responsible for approximately 1.7 million new cases in 2012 [1]7KHDJHLQJRIWKHZRUOG¶V
population, the notable increase in life expectancy, the sharp tendency towards adoption of a 
westernized lifestyle including lower fertility and sedentary, shorter duration of breastfeeding, 
and the raising prevalence of obese and diabetic subjects, represent an accumulation of factors 
known to be associated with breast cancer that will contribute to the continual increase in the 
global burden of this cancer [2]. A public health priority is the identification of environmental 
or lifestyle factors whose modification could lead to reductions in breast cancer occurrence. 
Adiposity, alcohol consumption, and physical inactivity are modifiable risk factors that would 
contribute to 25% of breast cancer cases in France, 33% in USA, 38% in the United Kingdom, 
22% in Brazil and 11% in China [3, 4]. The preventive potential of physical activity was 
unveiled by a small study on 69 breast cancers that found a 44% (95% CI (0, 77)) reduced rate 
of breast cancer among female college athletes [5]. Since then, epidemiological studies have 
generally corroborated the inverse association between physical activity and breast cancer [6, 
7]. However, the magnitude of the reduction in breast cancer risk associated with physical 
activity remains imprecise because of the variability in the way epidemiological studies 
measured physical activity, analysed data and reported results.  
Higher levels of circulating oestrogen and androgen are related to higher breast cancer risk [8-
10], and studies among postmenopausal women consistently showed that physical activity can 
reduce serum levels of these hormones [11, 12]. Use of hormone replacement therapy (HRT) 
increases levels of circulating sex-hormones and the risk of breast cancer [13, 14]. A question 
is thus whether HRT use could influence the preventative effect of physical activity.  
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In this study, we quantified the association between physical activity and breast cancer risk in 
prospective studies, exploring in more depth the influence that exposure assessment and 
breast cancer risk factors, especially HRT use, could have on this association. Risk reductions 
associated with measurable amounts of physical activity were also evaluated. 
Materials and Methods 
Literature search and study selection 
A systematic literature search and quantitative analysis was conducted following PRISMA 
guidelines [15]. This search was restricted to articles published in English language up to 
November 2014 and available in the following database: Ovid MEDLINE database, ISI Web 
of Science, Science Citation Index Expanded, and PUBMED. A combination of key words 
DQG0HV+LQGH[WHUPVZDVXVHGLQFOXGLQJ³EUHDVWQHRSODVP´RU³EUHDVWFDQFHU´³SK\VLFDO
DFWLYLW\´RU³SK\VLFDOH[HUFLVH´RU³PRWRUDFWLYLW\´³FRKRUWVWXG\´RU³SURVSHFWLYHVWXG\´RU
³ORQJLWXGLQDOVWXG\´7KHUHIHUHQFHOLVWVRIUHWULHYHGDUWLFOHVZHUHDOVRKDQGVHDUFKHG(OLJLEOH
articles for this study had to (i) report data on incident cases of breast cancer; (ii) report 
measurement of physical activity, being occupational and/or non-occupational; (iii) have a 
prospective design. As case-control studies are more prone to recall and selection biases, and 
thus to provide less accurate risk estimates, this systematic review focused only on studies 
with prospective design. 
Titles and abstracts were screened for eligibility. Full copies of eligible articles were retrieved 
and fully read by at least two co-authors. When several articles were published on the same 
study, the most recent publication was selected, except for those data that were relevant for 
sub-analyses. 
Data extraction 
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Extraction of main study characteristics, exposure assessment and relative risks was done by 
one co-author in a pre-defined database. The resulting table was checked by another author 
and by a statistician. All relative risks (RR) with the corresponding 95% confidence interval 
(CI) were extracted for each category of physical activity. As a rule, we selected the most 
adjusted RRs associated with the most comprehensive measure of physical activity that was 
RIWHQODEHOOHGDV³WRWDOSK\VLFDODFWLYLW\´ 
Statistical Methods 
Various risk estimates (RR) and their 95% CI were transformed into log (RR) and their 
corresponding variances were computed. When no RR was reported, tabular data were used to 
calculate the crude estimates and 95% CIs. In the case of a RR reported separately by type of 
physical activity (i.e., occupational or non-occupational activity) or by menopausal status, a 
fixed-effect modelling was used to combine all the RRs in order to get a global result for the 
main analysis (Table S1). From the transformed data, summary relative risks (SRR) were 
computed using a random effects model [16] and the confidence intervals were based on the t-
distribution. As physical activity assessment and reporting of results were very heterogeneous 
across studies, breast cancer risk associated with the highest level of physical activity was 
compared with the lowest level of physical activity.  
Heterogeneity across studies was evaluated by the I2 statistic, which represents the percentage 
of total variation across studies that is attributable to heterogeneity rather than to chance [17]. 
Three tests for publication bias were performed, the Begg test [18], the Egger test [19] and the 
Macaskill test [20].  
Subgroup meta-analyses were conducted according to the study location, the period of study 
(before 1989 vs. after 1989; based on the mid-year of each cohort), the type of physical 
activity (non-occupational vs. occupational), and the metric used to quantify physical activity 
(MET-h/week, hours/week or no quantitative measure). Regarding hormone receptor status, 
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results for ER+ and triple negative (ER-/PR-/HER2-) tumours were used as approximation of 
ER+/PR+ and ER-/PR- tumours respectively, in two studies [21, 22]. Stratified meta-analyses 
were performed considering risk factors for breast cancer, including menopausal status, HRT 
use, and adiposity. For adiposity, RRs for the most extreme BMI categories reported by 
articles were used. 
A dose-response analysis was conducted with studies reporting physical activity either in 
hours/week or in MET-h/week. The great variability in MET-h/weeks reported by studies 
precluded the possibility to perform a dose-response analysis as proposed by Greenland and 
Longneker [23]. We thus opted for a non-parametric approach in which ranks of physical 
activity levels expressed as MET-h/week or as hours/week were re-scaled so that exposure 
categories of all studies had the same range of values. Each study was scaled to share the first 
(reference) and last category of physical activity, whatever the number of categories defined 
by studies. Because there were three, four and five possible categories of MET-h/week, cut-
points were arbitrarily assigned a priori at 0, 1, 1.33, 2, 2.67, 3 and 4. Hence, if in a study, 
there were three categories of MET-h/week, category limits were 0 (reference), 2 and 4. The 
same method was applied to the hours/week analysis but six categories of physical activity 
were used and cut-points were assigned at 0, 1, 1.25, 1.67, 2, 2.5, 3, 3.33, 3.75, 4 and 5. Then, 
RRs reported by studies were plotted against re-scaled exposure categories. In order to 
estimate a summary slope, a linear regression of the log (RR) according to physical activity 
categories, weighted by the inverse variance of log (RR), was conducted for each study. Then, 
a meta-analysis of the slopes of each linear model was performed using a random-effect 
modelling. All the analyses were carried out in programming language R (version 3.1.2, GNU 
General Public License, 2014). 
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Results 
Study selection and description 
The literature search identified 928 potentially relevant studies, of which 60 met the inclusion 
criteria (Figure 1). Among the eligible studies, 22 were further excluded as they were 
duplicates of main or most recent articles (Table S2) leaving 38 studies in the final analysis. 
However, nine duplicate studies were included in stratified analyses as they provided results 
that were not reported in main or most recent articles. Selected and duplicate articles with 
relevant data are summarized in Table 1. [21, 22, 24-68] 
Studies included a total of 4,124,275 women of which 116,304 (2.8%) were diagnosed with a 
breast cancer during the study period. Most of these cancers were invasive but a small number 
of in-situ breast cancer were also included in few studies (see Table S3 for the type of cancer 
included in each study). Twelve percent of breast cancer cases were pre-menopausal, 45% 
were post-menopausal, and menopausal status was unknown for 43%.  
The way physical activity was assessed and reported varied across studies (Table 1 and Table 
S4). In most studies (24), physical activity related to the month(s) or year(s) preceding 
inclusion in the cohort. Three studies evaluated occupational physical activity only, 22 studies 
assessed non-occupational physical activity only, seven studies assessed both and reported 
results for each type of activity, and six studies assessed total physical activity without 
breakdown by type of physical activity.  
Eight studies reported physical activity measured in MET-h/week, nine reported duration of 
physical activity per day or per week and three reported in both units. Eighteen studies 
classified physical activity in discrete categories without use of measurement units to describe 
category boundaries. The lowest level of physical activity usually corresponded to being 
inactive, including sedentary and sitting.  
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Meta-analysis of all studies 
For all 38 studies, the SRR of breast cancer in the highest compared with the lowest category 
of physical activity was 0.88 (95% CI (0.85, 0.90)) (Figure 2). The I2 of 29% indicates 
moderate heterogeneity in risks between studies, mainly due to the five studies that found an 
increased risk. Careful reading of the five studies provided no clue on the reasons possibly 
underlying these findings, except Dorgan et al. 1994 [25] that specified that less than 5% of 
women reported regular vigorous physical activity. 
The SRR was not materially altered when meta-analysis was restricted to the 23 studies that 
assessed physical activity in the year(s) preceding inclusion in cohorts, or to the 18 studies 
that included invasive cancer only, or after exclusion of the Moradi et al. 1999 [31] study that 
included 37% of all breast cancer patients in the meta-analysis (data not shown).  
Stratified analysis 
The location of studies, the BMI of women or the adjustment for BMI did not influence risk 
reductions associated with physical activity (Figure 3). Risk reductions were similar in pre- 
and post-menopausal women, but menopausal status was unknown for 43% of women.  
A greater reduction of breast cancer risk was observed in studies conducted before 1989 than 
after, but all the heterogeneity in results was confined to studies conducted before 1989. The 
SRR for studies conducted before 1989 was 0.78 (95%CI (0.69, 0.88)) when the Moradi et al. 
1999 [31] study was excluded. 
Risk reductions were greater in studies that measured physical activity in hours/week (19% 
reduction) than in MET-h/week (13% reduction) or in other units (11% reduction). The 
difference in risk reduction was essentially due to vigorous physical activity (e.g., activities 
like jogging associated with sweating) being more frequently reported in hours/weeks while 
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reporting in MET-h/week generally encompassed physical activities of any magnitude, from 
housekeeping to strenuous activity. 
Studies that measured both types of physical activity suggest that risk reductions were slightly 
more pronounced with non-occupational than with occupational physical activity.  
Regarding hormone receptor status, one study [38] reported risks for ER+/PR+ tumours but 
not for other tumours. For this reason, 10 studies were used to compute a SRR for ER+/PR+ 
tumours and nine studies were used for ER-/PR- tumours. Reduction in breast cancer risk was 
more pronounced for ER-/PR- tumours (SRR=0.80) than for ER+/PR+ tumours (SRR=0.89).  
HRT use was reported in 19 of the 36 studies conducted in the USA and in Europe. Sixty one 
percent of women reported never use of HRT and 39% reported ever use of HRT (i.e., current 
or past use). This utilization frequency remains the same in the six studies that examined the 
influence of physical activity according to HRT use (Table 2).[35, 42, 50, 55, 56, 66] 
Although the SRR for the six studies was 0.88, breast cancer relative risks associated with 
highest level of physical activity were always smaller for never users of HRT than for ever 
users. Overall, it seemed that the entire preventive effect was confined to women who never 
used HRT (SRR=0.78) as no risk reduction was noticeable in women who reported ever use 
of HRT (SRR=0.97). The absence of overlapping between the confidence interval around 
SRRs for never and ever users of HRT indicates statistically significant effect modification 
(confirmed by meta-regression: p<0.05). There was no heterogeneity in results across the six 
studies.  
Dose-response analysis 
Dose-response analyses were performed with the 11 studies that reported physical activity in 
MET-h/week and the 11 studies that reported duration of physical activity in hours/week. 
Significant dose-response relationships were found (p <0.0001) between amounts of physical 
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activity and breast cancer risk indicating steady reductions in risk with increasing physical 
activity, without evidence for a threshold (Figure 4).  
The reporting in MET-h/week usually encompassed all activities, being vigorous or not. 
Moreover, list of activities for which MET was estimated has continuously expended [69-71]. 
Consequently, the level of detail collected on physical activity varied across studies and scales 
of MET-h/week were very heterogeneous. For instance, Phipps et al. 2011 [21] used four 
FDWHJRULHVRIH[SRVXUHUDQJLQJIURPWR.5 MET-h/week, whereas Leitzmann et al. 2008 
[52] used five categories of physical activity ranging from 105 to 721 MET-h/week.  
Reporting of physical activity in hours/week was mostly related to vigorous physical activity 
only. Categories in hours/week were frequently imbalanced, with extreme categories 
populated with few women having unusually high levels of physical activity (Table 3) [22, 
37, 47, 49-51, 53-55, 57, 66]. To obtain more realistic data, the two highest levels of vigorous 
physical activity were combined and RR were recomputed using a fixed-effect meta-analysis, 
in three studies [22, 50, 55]. After these modifications of exposure categories, the differences 
between lowest and highest levels of physical activity ranged from 3 to 7 hours/week with a 
mean of 5 hours/week. Women spending at least 5 hours/week of mainly vigorous activity 
had an 18% (95%CI (13, 23)) reduction in breast cancer risk compared with women who had 
no or limited vigorous physical activity. 42% of women included in these 11 studies ever used 
HRT and assuming that physical activity does not reduce the risk of breast cancer in women 
who ever used HRT, it is possible to estimate the risk reduction associated with 5hours/week 
or more of mainly vigorous physical activity in never HRT users (i.e., from resolution of the 
equation 0.42 RReverHRT + 0.58*RRneverHRT = 0.82, assuming RReverHRT = 1). A sustained 
change from being physically inactive to engaging in 5 hours/week or more of mainly 
vigorous physical activity could lead to a 31% (95%CI (22, 40)) risk reduction in women who 
never used HRT.  
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Discussion  
This meta-analysis demonstrates three important findings. First, increased levels of physical 
activity lead to reductions in the risk of breast cancer irrespective of the type of physical 
activity, place of residence, adiposity, menopausal status, and the hormone receptor status of 
tumours. Second, breast cancer risk seems to decline with increasing physical activity, 
without a threshold effect. Third, women who ever used HRT had no reduction of breast 
cancer risk associated with physical activity. Despite limitations in quantification and 
reporting of exposure, heterogeneity in study results was moderate suggesting that most 
studies consistently found reduced risks of breast cancer associated with increasing levels of 
reported physical activity.  
This meta-analysis has several limitations. First, dose-response meta-analysis using all studies 
was not performed because quantification and reporting of physical activity was too 
heterogeneous across studies. If in most studies the lowest level of physical activity coincided 
with sedentary, it was often difficult to figure out the meaning, in term of quantity, of levels 
ODEHOOHGDV³PRGHUDWH´RU³KLJK´SK\VLFDODFWLYLW\6HFRQGLQFOXVLRQRIin-situ breast cancer 
could have weakened the preventive effect of physical activity. Four studies that examined 
risk of in-situ breast cancer in relation to physical activity found no or equivocal association 
[51, 57, 72, 73]. However, the meta-analysis restricted to studies that included invasive cancer 
only showed no difference in SRR. Third, stratified results on menopausal status could be 
biased as menopausal status of women was unknown in 43% of women and many studies did 
not report results according to menopausal status.  
Four, the result related to HRT use could arise from selection bias since only six studies 
examined the influence of physical activity according to HRT use. Moreover, it is known that 
the HRT-induced risk of breast cancer steadily vanishes in the 5-7 years after HRT use 
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discontinuation but, for past users, data on time since last HRT use were not available in 
publications. However, results of the six studies were highly consistent, there was no evidence 
of heterogeneity, and the 95% CI around SRRs for ever and for never HRT use did not 
overlap. Therefore, our study raises the hypothesis that HRT use could nullify the protection 
conferred by physical activity against breast cancer. This hypothesis is supported by 
knowledge that a steroid-hormone pathway may play a role in the association between 
physical activity and breast cancer risk [8-10] and that physical activity can reduce serum 
levels of these hormones in postmenopausal women [11, 12]. Hence, if physically active 
women have a reduced risk of breast cancer risk through reductions of circulating oestrogens, 
then HRT use would cancel out this effect because of re-establishment of oestrogen blood 
concentrations as if women were physically inactive. Moreover, breast cancers induced by 
HRT use are more frequently ER+/PR+ than other breast cancers [74-76] which could explain 
the smaller risk reduction obtained for ER+/PR+ than for ER-/PR- tumours. HRT use was less 
prevalent before 1990 than during the 1990 to 2002 period [77], after which dramatic 
UHGXFWLRQVLQXVHRFFXUUHGIROORZLQJWKHSXEOLFDWLRQRI:RPHQ¶V+HDOWK,QLWLDWLYHWULDO[13] 
and the Million Women Study [14] that documented the association between HRT use and 
breast cancer. Studies on physical activity in the USA and Northern Europe were, in their 
PDMRULW\FRQGXFWHGLQWKH¶VZKHQODUJHSURSRUWLRQVRISHUL- and post-menopausal 
women used HRT over long periods of time. Consequently, massive presence of HRT users in 
cohorts might have led to underestimation of risk reductions expected with physical activity. 
It may also explain why risk reductions were of 20% in studies conducted before 1989 and of 
11% in more recent studies. 
Physical inactivity is usually associated with adiposity, and adiposity is a risk factor for both 
breast cancer occurrence and mortality [78, 79]. However, the stratified analyses according to 
ZRPHQ¶s BMI or to adjustment for BMI showed no change in SRRs. A similar independence 
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of risk associated with physical activity was found by the IARC review [6]. These results 
indicate that the protective effect of physical activity would be the same at all levels of 
overweight and obesity. Nevertheless, independently from adiposity, it is well known that 
weight gain is an important risk factor for breast cancer in post-menopausal women, 
especially in women not taking HRT [80]. Physical activity could be critical for 
preventing weight gain and consequently breast cancer. Unfortunately, most of the 
studies did not report on weight changes during the follow-up, therefore our meta-
analysis could not examine the combined effect of physical activity and weight 
changes on the risk of breast cancer. 
Systemic inflammation is probably a main factor on which physical activity exerts 
considerable influence. Low grade systemic inflammation is practically always present in 
obesity, diabetes, sedentary, old age, and is associated with aggressive breast cancer 
phenotype (e.g., ER-/PR- and triple negative) and poor prognosis [81-83]. Randomized trials 
have shown that increasing physical activity reduces systemic inflammation [84-86]. The 
influence on systemic inflammation would explain why physical activity seems capable of 
reducing the risk of breast cancers whatever the hormone receptor status, the menopausal 
status and the adiposity of women.  
This study indicates that avoidance of sedentary behaviours and promotion of physical 
activity may contribute to control the increase in breast cancer burden taking place in most 
populations over the world. However, even in women who never used HRT, substantial 
amounts of physical activity are needed for expecting 20% or more reductions in breast 
cancer risk. It is not sure that large proportions of women with no or low level of physical 
activity would be willing, find the time and have the physical aptitude to engage in at least 5 
hours/week of strenuous physical activity on the long term. A more realistic perspective 
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indicated by study findings is that a physically inactive women engaging in at least 150 
minutes per week of vigorous physical activity would reduce their lifetime risk of breast 
cancer by 9%, a reduction that might be two times greater in women who never used HRT. 
Nonetheless, risk reductions were estimated from observational studies which do not 
necessarily provide a reliable reflection of actual changes in risk that would be associated 
with public health actions on decreasing sedentary and increasing physical activity. The time 
is ripe for organizing large population randomized trials that will better inform on the 
feasibility of policies encouraging physical activity to prevent breast cancer occurrence. On 
the other hand, other lifestyle risk factors such as alcohol drinking that are known to be 
associated with an increased risk of breast cancer should also be considered in strategies 
aiming at preventing breast cancer.  
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Figure captions 
Figure 1. Flow chart of the literature search strategy to identify cohort studies on breast 
cancer risk and physical activity. 
Figure 2. Forest plot of meta-analysis of breast cancer risk according to physical activity 
level in women. Individual studies are represented with their RR and 95% CI (highest versus 
lowest category of physical activity). The square size is proportional to the variance of the RR 
and the horizontal lines represent the corresponding 95% CI. Heterogeneity between studies 
was assessed through Q and I² statistics. Publication bias was evaluated using Begg, Egger 
and Macaskill tests. 
Figure 3. Results from stratified analyses.  
Figure 4. Dose-response relationship between breast cancer risk and physical activity in 
studies that measured physical activity in MET-h per week (A) or in hours per week (B).  
A. MET-h/week B. Hours/week 
Web extra material 
Table S1 ± Details on computation and data extraction. 
Table S2 ± Duplicate studies that were excluded from main analysis. 
Table S3 ± Breast cancer types included in prospective studies. 
Table S4 ± Assessment of physical activity in prospective studies (duplicate studies from 
which some data were used are in light grey)  
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Tables  
Table 1: Main characteristics of cohort studies included in the meta-analysis, ranked by year of publication. Duplicate articles not used 
for the main meta-analysis but from which selected data were used in sub-analyses are highlighted in grey. 
First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
Paffenbarger, 1987 
[24] 
USA 
Alumni from the 
University of 
Pennsylvania 
4,706 
(46) 32 NR PreM/PostM Non-occ 
Early 
college 
KZNYVKZN
of sport b - Nadj 
Dorgan, 1994 [25] 
USA 
Framingham Heart 
Study (FHS) 
2,298 
(117) 28 35-68 PreM/PostM 
Occ and 
non-occ c 
Baseline 
Index combining 
hours per day of 
sedentary, moderate 
and heavy PA 
(during work and 
leisure time) 
- Nadj 
Steenland, 1995 
[26] d 
USA 
National Health 
and Nutrition 
Examination 
Survey I 
(NHANES I) 
NR  
(163) 16 25-74 PreM/PostM Occ Baseline Little, some, a lot PostM Adj 
Fraser, 1997 [27] 
USA 
Adventist Health 
Study 
20,341 
(218) 6  PreM/PostM 
Occ and 
non-occ c 
Baseline Low, moderate, high - Adj/Nadj 
Thune, 1997 [28] 
Norway 
National Health 
Screening Service 
25,624 
(351) 14 20-54 PreM/PostM 
Occ and 
non-occ 
Baseline 
Non-occupational: 
sedentary, moderate, 
regular exercise; 
Occupational: 
sedentary, walking, 
lifting or heavy 
manual labor 
BMI, 
PreM/PostM Adj/Nadj 
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
Cerhan, 1998 [29] 
USA 
Iowa 65+ Rural 
Health Study 
1,806 
(46) 11 65-102 PostM Non-occ Baseline 
Any disability, 
inactive, moderately 
active, highly active 
(based on 5 
questions about non-
occupational PA and 
housework) 
PostM Adj e 
Sesso, 1998 [30] 
USA 
College Alumni 
Health Study 
1,566 
(109) 23 37-69 PreM/PostM Non-occ Baseline 
Weekly energy 
expenditure in kcal 
per week 
BMI, 
PreM/PostM Adj 
Moradi, 1999 [31] 
Sweden 
Swedish Cancer 
Environment 
Register III 
(CERIII) 
1,687,174 
(43,259) f 19 NR PreM/PostM Occ 
Adult life 
(1960 and 
1970 
censuses) 
Occupational PA 
classified as 
sedentary, light, 
moderate, high/very 
high 
- Nadj 
Luoto, 2000 [32] 
Finland 
Finish Adult health 
behaviour survey 
30,548 
(332 g) 9 15-64 PreM/PostM Non-occ Baseline 
Leisure time: 
<once/wk, once/wk, 
2-3 times/wk, daily 
Commuting to work: 
work at home, 
commuting by car,  
<30 min/day 
walking/bicycling, 
PLQGD\
walking/bicycling 
BMI, 
PreM/PostM Adj 
Wyrwich, 2000 
[33] 
USA 
Longitudinal Study 
on Aging (LSOA) 
3,131 
(77) 7 70-98 PostM Non-occ Baseline 
Any disability, 
inactive, moderate, 
high 
PostM Adj e 
Wyshak, 2000 [34] 
USA US Alumni 
3,908 
(175) 15 
53 
(mean) PreM/PostM Non-occ College 
Former athletes 
versus former non-
athletes 
- Nadj 
Moore, 2000 [35] h 
USA 
,RZD:RPHQ¶V
Health Study 
37,105 
(1,380) 10 55-69 PostM Non-occ Baseline Low, medium, high 
BMI, HRT, 
PostM Adj/Nadj 
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
Breslow, 2001 [36] 
USA 
National Health 
Epidemiologic 
follow-up study 
(NHEFS, arised 
from NHANES I) 
6,160 
(138) 9 24-75 PreM/PostM Non-occ 
Long term 
PA 
(baseline 
and 10y 
before) 
Low, moderate, high BMI, PreM/PostM Adj 
Dirx, 2001 [37] 
The Netherlands 
Netherlands 
Cohort Study 
(NLCS) 
2,924 
(1,208) 7 55-69 PostM 
Occ and 
non-occ 
Lifetime for 
occupational 
PA and 
baseline for 
non-
occupational 
PA 
Minutes per day for 
non-occupational 
PA and kJ/min for 
occupational PA 
(energy expenditure) 
BMI, PostM Nadj 
Lee, 2001 [38] 
USA 
Women's Health 
Study (WHS) 
39,322  
(411) 4  PreM/PostM Non-occ 
Baseline 
(past year) 
4 categories of 
energy expended 
during PA in 
kJ/week 
ER/PR i, 
PostM Adj/Nadj 
Moradi, 2002 [39] 
Sweden 
Swedish Twin 
Registry 
9,539 
(506) 24 42-70 PreM/PostM 
Occ and 
non-occ 
Adult life 
(25-50 
years) 
Non-occupational: 
sedentary, moderate, 
regular PA; 
Occupational: 
Sedentary, active, 
Strenuous 
BMI, 
PreM/PostM Nadj 
Rintala, 2002 [40] 
Finland Finnish citizen 
680,000 
(17,986) 24  PreM/PostM Occ 
Baseline, at 
age 20 and 
at age 35 
Five categories of 
occupational PA: 
class 1+2, class 3, 
class 4, class 5 
PreM/PostM Nadj 
McTiernan, 2003 
[41] j 
USA 
Women Health 
Initiative (WHI) 
74,171 
(1,780) 5 50-79 PostM Non-occ Baseline 
MET-hours per 
week BMI, PostM Adj 
Patel, 2003 [42] k 
USA 
American Cancer 
Society Cancer 
Prevention Study 
II Nutrition Cohort  
72,608 
(1,520) 5 50-74 PostM Non-occ 
Baseline 
(past year) 
MET-hours per 
week 
BMI, HRT, 
PostM 
Adj/Nadj 
e
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
(CPS-II nutrition 
Cohort) 
Rintala, 2003 [43] 
Finland 
Finnish female 
physical education 
and language 
teachers 
10,049 
(465) 34 >25 PreM/PostM Occ Lifetime 
Physical education 
teachers (high 
lifetime PA) vs. 
language teachers 
(low lifetime PA) 
PreM/PostM Nadj 
Margolis, 2005 
[44] 
Norway, Sweden 
:RPHQ¶V/LIHVW\OH
and Health Study 
99,504 
(1,166) 9 30-49 PreM/PostM Non-occ Baseline 
5 levels of PA: 
none, low, 
moderate, high, 
vigorous 
PreM/PostM Adj 
Schnohr, 2005 [45] 
Denmark 
Copenhagen 
Centre for 
Prospective 
Population Studies  
13,216  
(417) 14 20-93 PostM Non-occ 
Baseline 
(past year) 
3 levels of PA: low, 
moderate and 
vigorous 
PostM Adj/Nadj 
Bardia, 2006 [46] 
USA 
,RZD:RPHQ¶V
Health Study 
41,836 
(2,548) 18 55-69 PostM Non-occ Baseline Low, medium, high 
ER/PR, 
PostM Adj/Nadj 
Chang, 2006 [47] 
USA 
Prostate, Lung, 
Colorectal and 
Ovarian Cancer 
Screening Trial 
(PLCO) 
27,541 
(764) 
9 
(median 
5) 
55-74 PostM Non-occ Baseline Hours per week PostM Adj/Nadj 
Mertens, 2006 [48] 
USA 
Atherosclerosis 
risk in 
communities 
(ARIC) 
7,994 
(342) 13 45-64 PreM/PostM 
Occ and 
non-occ 
Baseline 
Quartile of PA 
based on Baecke 
indices 
PostM Nadj 
Silvera, 2006 [49] 
Canada 
Canadian National 
Breast Screening 
Study (NBSS) 
40,318 
(1,673) 16 40-59 PreM/PostM Non-occ 
Baseline 
(past one 
month) 
Minutes per day BMI, PreM/PostM Adj/Nadj 
Tehard, 2006 [50] 
France 
E3N cohort of 
French teachers 
(E3N) 
90,509 
(3,424) 12 40-65 PreM/PostM Non-occ Baseline 
Total PA in MET-
hours per week;  
Vigorous 
BMI, HRT Adj/Nadj 
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
recreational PA in 
hours per week 
Dallal, 2007 [51] 
USA 
California 
Teachers Study 
110,599 
(2,649) 7 20-79 PreM/PostM Non-occ 
Lifetime 
(between 
high school 
and current 
age) 
Hours per week BMI, ER/PR, PreM/PostM Adj/Nadj 
Leitzmann, 2008 
[52] 
USA 
Breast Cancer 
Detection 
Demonstration 
Project Follow-up 
Study (BCDDP) 
32,269 
(1,506) 8 40-93 PostM 
Occ and 
non-occ c 
Baseline 
(past year) 
MET-hours per 
week 
BMI, ER/PR, 
PostM Adj/Nadj 
Maruti, 2008 [53]l 
USA 
1XUVHV¶+HDOWK
Study II (NHS II) 
64,777 
(550) 6 33-51 PreM Non-occ 
Adolescence 
and adult 
(from age 
12 to current 
age) 
Total PA in MET-
hours per week; 
Strenuous activity in 
hours per week 
BMI, ER/PR, 
PreM Nadj 
Suzuki, 2008 [54] 
Japan 
Japan 
Collaborative 
Cohort Study 
(JACC) 
30,157 
(207) 12 40-69 PreM/PostM 
Occ and 
non-occ c 
Baseline 
Minutes per day 
(time spent walking) 
and hours per week 
(time spent 
exercising) 
BMI, 
PreM/PostM Adj/Nadj 
Howard, 2009 [55] 
USA 
U.S. Radiologic 
Technologists 
cohort (USRT) 
45,631 
(864) 9 47 PreM/PostM 
Occ and 
non-occ c 
Baseline 
(past year) 
Total PA in MET-
hours per week; 
Strenuous exercise 
in hours per week 
HRT, 
PreM/PostM Adj/Nadj 
Peters, 2009 [56] m 
USA 
National Institutes 
of Health-
American 
Association of 
Retired Persons 
Diet and Health 
182,862 
(5,433) 7 50-71 PostM 
Occ and 
non-occ c 
Baseline 
(past year) 
Times per week 
(Inactive, <1/wk, 1-
2/wk, 3-4/wk, 
ZN 
BMI, ER/PR, 
HRT, PostM Adj/Nadj 
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
Study  
(NIH-AARP) 
Peters, 2009 [57] m 
USA 
National Institutes 
of Health-
American 
Association of 
Retired Persons 
Diet and Health 
Study  
(NIH-AARP) 
118,899 
(3,522) 7 50-71 PostM Non-occ 
Past 10 
years Hours per week 
ER/PR n, 
PostM Nadj 
George, 2010 [58] 
m 
USA 
National Institutes 
of Health-
American 
Association of 
Retired Persons 
Diet and Health 
Study  
(NIH-AARP) 
97,039 
(2,866) 7 50-71 PostM Occ Baseline 
5 levels of activity: 
sitting all day; 
sitting and a little 
walking; standing or 
walking, no lifting; 
lifting or carrying 
light loads, or 
climbing stairs 
often; heavy lifting 
or carrying 
PostM Adj 
Eliassen, 2010 [59] 
USA 
1XUVHV¶+HDOWK
Study (NHS) 
95,396 
(4,782) 20 40-65 PostM Non-occ 
Baseline 
(past year) 
and update 
every 2 or 4 
years 
MET-hours per 
week 
ER/PR, 
PostM Adj/Nadj 
Pronk, 2011 [60] 
China 
Shanghai Women's 
Health Study 
(SWHS) 
73,049 
(717) 9 40-70 PreM/PostM 
Occ and 
non-occ 
Non-occ PA 
in past year 
and 5 years 
before 
interview. 
Lifetime occ 
PA. 
Non-occupational: 
MET-hours per 
week per year; 
Occupational: 
energy expenditure 
in kJ per min per 
year 
BMI, 
PreM/PostM Nadj 
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
Phipps, 2011 [21] 
USA 
Women Health 
Initiative (WHI) 
155,723 
(2,917) 8 50-79 PostM Non-occ Baseline 
MET-hours per 
week 
ER/PR o, 
PostM Adj 
Suzuki, 2011 [61] 
Japan 
Japan Public 
Health Center-
based Prospective 
Study (JPHC) 
53,578 
(652) 15 40-69 PreM/PostM 
Occ p and 
non-occ 
Baseline 
and updated 
 5 years 
after 
MET-hours per day; 
no data for 
occupational PA 
only but for leisure 
time only (in days 
per month or per 
week) 
BMI, ER/PR, 
PreM/PostM Adj/Nadj 
Steindorf, 2013 
[62] 
Europe 
European 
Prospective 
Investigation into 
Cancer and 
Nutrition (EPIC) 
257,805 
(8,034) 12 35-70 PreM/PostM 
Occ and 
non-occ 
Baseline 
(past year 
for non-occ 
PA and 
current for 
occ PA) 
MET-hours per 
week for non-
occupational PA; 
4 categories for 
occupational PA 
(sedentary; 
Standing; Manual 
and heavy manual; 
non-worker) 
BMI, ER/PR, 
PreM/PostM Adj 
Hildebrand, 2013 
[63] 
USA 
American Cancer 
Society Cancer 
Prevention Study 
II Nutrition Cohort  
(CPS-II nutrition 
Cohort) 
73,615 
(4,760) 
17 
(median 
14) 
50-74 PostM Non-occ 
Baseline 
and updated 
3 times 
during 
follow-up 
MET-hours per 
week for total non-
occupational PA 
PostM Adj e 
Hastert, 2013 [64] 
USA 
Vitamins and 
Lifestyle study 
cohort  (VITAL) 
30,797 
(899) 7 50-76 PostM Non-occ 
Past 10 
years 
Be physically active 
vs. be physically 
inactive according to 
WCRF/AICR cancer 
prevention 
recommendations. 
PostM Adj/Nadj 
Rosenberg, 2014 
[22] 
USA 
Black Women's 
Health Study 
(BWHS) 
44,708 
(1,364) 16  PreM/PostM Non-occ 
Baseline 
(past year) Hours per week 
b
 
BMI, ER/PR 
o
, 
PreM/PostM 
Nadj 
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
Borch, 2014 [65] q 
Norway 
Norwegian 
Women and 
Cancer Study 
(NOWAC) 
80,202 
(1,767) 8 34-70 PostM 
Occ and 
non-occ c 
Baseline 
5 levels of PA: very 
low, low, moderate, 
high, very high 
ER/PR, 
PostM Adj 
e
 
Catsburg, 2014 
[66] 
Canada 
Canadian Study of 
Diet, Lifestyle and 
Health (CSDLH) 
4,393 
(1,094) 15 
59 
(mean) PreM/PostM Non-occ Baseline 
Hours per week and 
MET-hours per 
week 
BMI, HRT, 
PreM/PostM Adj 
Brinton, 2014 [67] 
USA 
National Institutes 
of Health-
American 
Association of 
Retired Persons 
Diet and Health 
Study  
(NIH-AARP) 
190,872 
(7,384) 9 50-71 PostM 
Occ and 
non-occ c 
Baseline 
(past year) 
Times per week 
(never/rarely,1-
3/month, 1-2/wk, 3-
ZNZN 
PostM Adj 
Boeke, 2014 [68] 
USA 
1XUVHV¶+HDOWK
Study II (NHS II) 
75,669 
(2,697) 14 25-42 PreM/PostM Non-occ 
Adolescence 
and adult 
(from age 
12 to current 
age) 
Total PA in MET-
hours per week b 
ER/PR n, 
PreM/PostM Nadj 
PA: physical activity; Occ: occupational PA; Non-occ: non-occupational PA; NR: data not reported; MET: metabolic equivalent of task. 
PostM: Post-menopausal women; PreM: Pre-menopausal women. 
BMI: Body mass index; HRT: Hormone replacement therapy; ER: Estrogen receptor; PR: Progesterone receptor. 
a
 Reported RR was adjusted for BMI: Adj: adjusted; Nadj: not adjusted; Adj/Nadj: both results were available (adjusted and not adjusted). 
b These studies were not used for the dose-response analysis because RRs were reported for dichotomous exposure (Paffenbarger 1987) or only a high vs. low result was 
reported in the text (Rosenberg 2014 and Boeke 2014). 
c
 Occupational and non-occupational PA were not distinguished.  
d
 This study was only used for the stratified analysis on the type of PA as it used the same cohort as Breslow 2001 and reported data on occupational PA. 
e
 RRs reported in the article were adjusted for BMI but as we recomputed RRs from cases and PYs we considered them as not adjusted for BMI in our analyses (see table 
S3). 
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First author, year 
Country Study name 
No. subjects  
(No. cancer 
cases) 
Years of 
follow-up 
Age of 
women 
Menopausal 
status 
Type of 
PA 
Period in 
life for PA Reporting of PA 
Risk factor 
stratification 
BMI  
adjusted 
a
 
f
 Data from the Swedish nationwide censuses in 1960 and 1970. We did not take the third cohort (women with the same job in 1960 and 1970) since it overlapped with the 
1960 and 1970 censuses.  
g
 "Whether all the women were cancer-free at the start of the follow-up was not evaluated".  
h
 This study was only used for the stratified analysis on BMI and HRT use as this is the same cohort as Bardia 2006.  
i
 Only RR for ER+/PR+ tumours was reported in this study. 
j
 This study was only used for the stratified analysis on BMI as this is the same cohort as Phipps 2011.  
k
 This study was only used for the stratified analyses on BMI and HRT use as this is the same cohort as Hildebrand 2013.  
l
 This study was only used for the stratified analyses on hours/week, BMI and hormone receptor status as this is the same cohort as Boeke 2014. This study was also used for 
the dose-response analysis in  MET-h/wk 
 instead of Boeke 2014. 
m
 These studies used the same cohort as Brinton 2014, hence they were only used for the stratified analyses: Peters 2009 (october) for the analyses on hours/week and non-
occupational PA; Peters 2009 (january) for the stratified analyses on BMI, HRT use and hormone receptor status; George 2010 for the occupational analysis. 
n
 This study did not report ER/PR status but ER+ and ER- breast cancer. These stratified results were not used in our analyis. 
o
 This study did not report ER/PR status but ER+ and triple negative breast cancer hence ER+ was considered as a proxy of ER+/PR+ and triple negative as a proxy of ER-
/PR-. 
p
 RR for occupational PA only was not reported. 
q
 This study was only used for the stratified analysis on ER/PR status as the cohort was included in Margolis 2005. 
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Table 2: Physical activity and risk of breast cancer according to HRT use. 
Never users Ever users  All women 
Study  Year of  
start/end 
Years of 
follow-up  
No. Women 
(No. BC)  RR [95%CI] 
No. Women 
(No. BC)  RR [95%CI] 
No. Women 
(No. BC)  RR [95%CI] 
Moore, 2000 [35] 1986/1995 10 22,429 (-) 0.89 [0.74; 1.06] 
13,934 
(-) 0.94 [0.76; 1.16] a  
37,105 
(1,380) 0.95 [0.83; 1.10] b 
Patel, 2003 [42] 1992/1997 5 35,013 (705) 0.64 [0.43; 0.95] c  
35,247 
(771) 0.87 [0.64; 1.19] cd 
72,608 
(1,520) 0.73 [0.51; 1.04] bc 
Tehard, 2006 [50] 1990/2002 12 65,554 (1,189) 0.79 [0.67; 0.94] e  
24,955  
(1,095) 1.01 [0.85; 1.21] 
90,509 
(3,424) 0.90 [0.80; 1.02] 
Howard, 2009 [55] 1994/2005 9 34,981 (139) 0.71 [0.43; 1.17] 
10,650 
(285) 1.15 [0.78; 1.70] 
45,631 
(864) 0.91 [0.74; 1.13] 
Peters, 2009 [56]  1995/2003 7 100,757 (2,528) f 0.76 [0.67; 0.86] 
82,105 
(4,073) f 0.97 [0.88; 1.08] 
182,862 
(5,433) f 0.86 [0.79; 0.94] b 
Catsburg, 2014 [66] 1995/2010 15 3,202 (724) 0.73 [0.55; 0.97] 
1,215 
(329) 0.83 [0.55; 1.26] 
4,393 
(1,094) 0.77 [0.61; 0.97] 
SRR 261,936 (5,285) 0.78 [0.70; 0.87] 
168,106 
(6,553) 0.97 [0.88; 1.07] 
433,105 
(13,715) 0.88 [0.81; 0.95] 
HRT: hormone replacement therapy; SRR: summary relative risk. 
a
 RRs corresponding to past and current users were combined using a fixed-effect meta-analysis in order to get an ever users group. 
b
 These results were not used in the main meta-analysis because these studies are duplicate with other studies. 
c As the reference category was not the first one reported, the first two categories were merged and RRs were recomputed from cases and PY. 
d Data from past and current users were taken into account to compute the RR for ever users. 
e As RR for HRT non-users was not reported, it was computed from cases and PY. 
f
 For the analysis on HRT use, both invasive and in-situ breast cancers were considered while for all women only invasive breast cancers were 
 considered. 
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Table 3: Summary of studies that reported three or more categories of physical activity duration per day or per week. 
First author, year of 
publication Type of PA 
Period of PA 
assessment No. categories 
% PYs 
in lowest 
PA 
category 
% PYs in 
highest 
PA 
category 
Lowest 
(h/w) 
Highest 
(h/w) 
RR 
highest 
vs. 
lowest 
95% CI 
Dirx, 2001 [37] Total non-occupational  Baseline  4 22% 22% <3.5 >10.5 0.76 0.58; 0.99 
Chang, 2006 [47] Vigorous non-
occupational Baseline  6 15% 21% 0  0.81 0.63; 1.05 
Silvera, 2006 [49] Vigorous non-
occupational 
Baseline (past one 
month) 4 28% 26% 0 >7 0.93 0.78; 1.10 
Tehard, 2006 [50] Vigorous non-
occupational Baseline  5 (3 after merging) 
ab
 57% 13% 0 (inactive)  0.79 0.71; 0.89 
Dallal, 2007 [51] Vigorous non-
occupational 
Lifetime - between 
high school and 
current age 
5 29% 11% <0.5 >5 0.8 0.69; 0.94 
Maruti, 2008 [53] Vigorous non-
occupational 
Lifetime - adolescence 
and adult (from age 12 
to current age) 
5 21% 21% <1  0.9 0.68; 1.18 
Suzuki, 2008 [54] 
Walking + exercise 
(occupational and non-
occupational combined) 
Baseline 3 NA NA NA NA 0.76 c 0.58; 1.00 
Howard, 2009 [55] 
Vigorous activity 
(occupational and non-
occupational combined) 
Baseline (past year) 5 (4 after merging) a 50% 9% 0  0.82 0.63; 1.06 
Peters, 2009 [57] Moderate/vigorous non-
occupational Past 10 years 5 14% 24% 0 or rarely >7 0.84 0.75; 0.94 
Rosenberg, 2014 [22] Vigorous non-
occupational Baseline (past year) 6 (5 after merging) 
a
 53% 13% <1  0.81 0.68; 0.98 
Catsburg, 2014 [66] Total non-occupational Baseline 5 21% d 16% d <1 >7.5 0.77 0.61; 0.97 
Summary relative risk               0.82 0.77;0.87 
PA: physical activity; PY: person-year; RR: relative risk; CI: confidence interval; NA: not available/applicable. 
a
 Two first categories were merged as the reference category was not the first one reported. 
b
 Two last categories were merged to get a category with at least 10% of subjects. 
c
 RR computed using a fixed effect meta-analysis, see Table S3. 
d
 % BC cases because PYs or No. of women in categories were not reported.  
 28 
References 
 
[1] Ferlay J, Soerjomataram I, Ervik M, Dikshit RP, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.1, 
Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International 
Agency for Research on Cancer; 2012. 
[2] Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet. 2005;365:1727-41. 
[3] World Cancer Research Fund. Cancer preventability statistics. United Kingdom. 
[4] Autier P, Boffetta P, Boniol M, Boyle P, Ferlay J, Al E. Attributable causes of cancer in France in the 
year 2000: IARC, Lyon; 2007. 
[5] Frisch RE, Wyshak G, Albright NL, Albright TE, Schiff I, Jones KP, et al. Lower prevalence of breast 
cancer and cancers of the reproductive system among former college athletes compared to non-athletes. Br 
J Cancer. 1985;52:885-91. 
[6] Vainio H, Bianchini F. IARC Handbooks of Cancer Prevention. Volume 6. Weight Control and 
Physical Activity. Lyon, France: IARC press; 2002. 
[7] Friedenreich C. Physical activity and breast cancer review of the epidemiologic evidence and biologic 
mechanisms. Recent Results Cancer Res. 2011;188:125-39. 
[8] Key T, Appleby P, Barnes I, Reeves G. Endogenous sex hormones and breast cancer in 
postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94:606-16. 
[9] Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and 
progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst. 
2004;96:1856-65. 
[10] Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE. Endogenous steroid hormone 
concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer 
risk? J Clin Oncol. 2006;24:1823-30. 
[11] McTiernan A. Effect of Exercise on Serum Estrogens in Postmenopausal Women: A 12-Month 
Randomized Clinical Trial. Cancer Res. 2004;64:2923-8. 
[12] McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, et al. Relation of 
BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring). 
2006;14:1662-77. 
[13] Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and 
benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's 
Health Initiative randomized controlled trial. JAMA. 2002;288:321-33. 
[14] Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. The Lancet. 
2003;362:419-27. 
[15] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and 
meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. 
 29 
[16] van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate 
approach and meta-regression. Stat Med. 2002;21:589-624. 
[17] Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-
58. 
[18] Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. 
Biometrics. 1994;50:1088-101. 
[19] Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315:1533-7. 
[20] Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-
analysis. Stat Med. 2001;20:641-54. 
[21] Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, et al. 
Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. 
Cancer Epidemiol Biomarkers Prev. 2011;20:454-63. 
[22] Rosenberg L, Palmer JR, Bethea TN, Ban Y, Kipping-Ruane K, Adams-Campbell LL. A prospective 
study of physical activity and breast cancer incidence in african-american women. Cancer Epidemiol 
Biomarkers Prev. 2014;23:2522-31. 
[23] Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, 
with applications to meta-analysis. Am J Epidemiol. 1992;135:1301-9. 
[24] Paffenbarger RS, Jr., Hyde RT, Wing AL. Physical activity and incidence of cancer in diverse 
populations: a preliminary report. Am J Clin Nutr. 1987;45:312-7. 
[25] Dorgan JF, Brown C, Barrett M, Splansky GL, Kreger BE, D'Agostino RB, et al. Physical activity 
and risk of breast cancer in the Framingham Heart Study. Am J Epidemiol. 1994;139:662-9. 
[26] Steenland K, Nowlin S, Palu S. Cancer incidence in the National Health and Nutrition Survey I. 
Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev. 
1995;4:807-11. 
[27] Fraser GE, Shavlik D. Risk Factors, Lifetime Risk, and Age at Onset of Breast Cancer. Ann 
Epidemiol. 1997;7:375-82. 
[28] Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med. 
1997;336:1269-75. 
[29] Cerhan JR, Chiu BCH, Wallace RB, Lemke JH, Lynch CF, Torner JC, et al. Physical Activity, 
Physical Function, and the Risk of Breast Cancer in a Prospective Study Among Elderly Women. J 
Gerontol. 1998;53A:M251-6. 
[30] Sesso HD, Paffenbarger RS, Jr., Lee IM. Physical activity and breast cancer risk in the College 
Alumni Health Study (United States). Cancer Causes Control. 1998;9:433-9. 
[31] Moradi T, Adami HO, Bergstrom R, Gridley G, Wolk A, Gerhardsson M, et al. Occupational 
physical activity and risk for breast cancer in a nationwide cohort study in Sweden. Cancer Causes 
Control. 1999;10:423-30. 
 30 
[32] Luoto R, Latikka P, Pukkala E, Hakulinen T, Vihko V. The effect of physical activity on breast 
cancer risk: a cohort study of 30,548 women. Eur J Epidemiol. 2000;16:973-80. 
[33] Wyrwich KW, Wolinsky FD. Physical Activity, Disability, and the Risk of Hospitalization for Breast 
Cancer Among Older Women. J Gerontol. 2000;55A:M418-21. 
[34] Wyshak G, Frisch RE. Breast cancer among former college athletes compared to non-athletes: a 15-
year follow-up. Br J Cancer. 2000;82:726-30. 
[35] Moore DB, Folsom AR, Mink PJ, Hong CP, Anderson KE, Kushi LH. Physical activity and 
incidence of postmenopausal breast cancer. Epidemiology. 2000;11:292-6. 
[36] Breslow RA, Ballard-Barbash R, Munoz K, Graubard BI. Long-term recreational physical activity 
and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up 
study. Cancer Epidemiol Biomarkers Prev. 2001;10:805-8. 
[37] Dirx MJ, Voorrips LE, Goldbohm RA, van den Brandt PA. Baseline recreational physical activity, 
history of sports participation, and postmenopausal breast carcinoma risk in the Netherlands Cohort Study. 
Cancer. 2001;92:1638-49. 
[38] Lee IM, Rexrode KM, Cook NR, Hennekens CH, Burin JE. Physical activity and breast cancer risk: 
the Women's Health Study (United States). Cancer Causes Control. 2001;12:137-45. 
[39] Moradi T, Adami HO, Ekbom A, Wedren S, Terry P, Floderus B, et al. Physical activity and risk for 
breast cancer a prospective cohort study among Swedish twins. Int J Cancer. 2002;100:76-81. 
[40] Rintala P, Pukkala E, Paakkulainen HT, Vihko VJ. Self-experienced physical workload and risk of 
breast cancer. Scand J Work Environ Health. 2002;28:158-62. 
[41] McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, Adams-Campbell LL, et al. Recreational 
physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative 
Cohort Study. JAMA. 2003;290:1331-6. 
[42] Patel AV, Callel EE, Bernstein L, Wu AH, Thun MJ. Recreational physical activity and risk of 
postmenopausal breast cancer in a large cohort of US women. Cancer Causes Control. 2003;14:519-29. 
[43] Rintala P, Pukkala E, Laara E, Vihko V. Physical activity and breast cancer risk among female 
physical education and language teachers: a 34-year follow-up. Int J Cancer. 2003;107:268-70. 
[44] Margolis KL, Mucci L, Braaten T, Kumle M, Trolle Lagerros Y, Adami HO, et al. Physical activity 
in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women's Lifestyle and 
Health cohort study. Cancer Epidemiol Biomarkers Prev. 2005;14:27-32. 
[45] Schnohr P, Gronbaek M, Petersen L, Hein HO, Sorensen TI. Physical activity in leisure-time and risk 
of cancer: 14-year follow-up of 28,000 Danish men and women. Scand J Public Health. 2005;33:244-9. 
[46] Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, et al. Recreational physical 
activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med. 
2006;166:2478-83. 
 31 
[47] Chang SC, Ziegler RG, Dunn B, Stolzenberg-Solomon R, Lacey JV, Jr., Huang WY, et al. 
Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, 
colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2006;15:334-41. 
[48] Mertens AJ, Sweeney C, Shahar E, Rosamond WD, Folsom AR. Physical activity and breast cancer 
incidence in middle-aged women: a prospective cohort study. Breast Cancer Res Treat. 2006;97:209-14. 
[49] Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE. Energy balance and breast cancer risk: a 
prospective cohort study. Breast Cancer Res Treat. 2006;97:97-106. 
[50] Tehard B, Friedenreich CM, Oppert JM, Clavel-Chapelon F. Effect of physical activity on women at 
increased risk of breast cancer: results from the E3N cohort study. Cancer Epidemiol Biomarkers Prev. 
2006;15:57-64. 
[51] Dallal CM, Sullivan-Halley J, Ross RK, Wang Y, Deapen D, Horn-Ross PL, et al. Long-term 
recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. 
Arch Intern Med. 2007;167:408-15. 
[52] Leitzmann MF, Moore SC, Peters TM, Lacey JV, Jr., Schatzkin A, Schairer C, et al. Prospective 
study of physical activity and risk of postmenopausal breast cancer. Breast Cancer Res. 2008;10:R92. 
[53] Maruti SS, Willett WC, Feskanich D, Rosner B, Colditz GA. A prospective study of age-specific 
physical activity and premenopausal breast cancer. J Natl Cancer Inst. 2008;100:728-37. 
[54] Suzuki S, Kojima M, Tokudome S, Mori M, Sakauchi F, Fujino Y, et al. Effect of physical activity 
on breast cancer risk: findings of the Japan collaborative cohort study. Cancer Epidemiol Biomarkers 
Prev. 2008;17:3396-401. 
[55] Howard RA, Leitzmann MF, Linet MS, Freedman DM. Physical activity and breast cancer risk 
among pre- and postmenopausal women in the U.S. Radiologic Technologists cohort. Cancer Causes 
Control. 2009;20:323-33. 
[56] Peters TM, Schatzkin A, Gierach GL, Moore SC, Lacey JV, Jr., Wareham NJ, et al. Physical activity 
and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol 
Biomarkers Prev. 2009;18:289-96. 
[57] Peters TM, Moore SC, Gierach GL, Wareham NJ, Ekelund U, Hollenbeck AR, et al. Intensity and 
timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP 
diet and health study. BMC Cancer. 2009;9:349. 
[58] George SM, Irwin ML, Matthews CE, Mayne ST, Gail MH, Moore SC, et al. Beyond recreational 
physical activity: examining occupational and household activity, transportation activity, and sedentary 
behavior in relation to postmenopausal breast cancer risk. Am J Public Health. 2010;100:2288-95. 
[59] Eliassen AH, Hankinson SE, Rosner B, Holmes MD, Willett W. Physical Activity and Risk of Breast 
Cancer Among Postmenopausal Women. Arch Intern Med. 2010;170:1758-64. 
[60] Pronk A, Ji BT, Shu XO, Chow WH, Xue S, Yang G, et al. Physical activity and breast cancer risk in 
 32 
[61] Suzuki R, Iwasaki M, Yamamoto S, Inoue M, Sasazuki S, Sawada N, et al. Leisure-time physical 
activity and breast cancer risk defined by estrogen and progesterone receptor status--the Japan Public 
Health Center-based Prospective Study. Prev Med. 2011;52:227-33. 
[62] Steindorf K, Ritte R, Eomois PP, Lukanova A, Tjonneland A, Johnsen NF, et al. Physical activity and 
risk of breast cancer overall and by hormone receptor status: the European prospective investigation into 
cancer and nutrition. Int J Cancer. 2013;132:1667-78. 
[63] Hildebrand JS, Gapstur SM, Campbell PT, Gaudet MM, Patel AV. Recreational physical activity and 
leisure-time sitting in relation to postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 
2013;22:1906-12. 
[64] Hastert TA, Beresford SA, Patterson RE, Kristal AR, White E. Adherence to WCRF/AICR cancer 
prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers 
Prev. 2013;22:1498-508. 
[65] Borch KB, Lund E, Braaten T, Weiderpass E. Physical activity and the risk of postmenopausal breast 
cancer - the Norwegian Women and Cancer Study. J Negat Results Biomed. 2014;13:3. 
[66] Catsburg C, Kirsh VA, Soskolne CL, Kreiger N, Bruce E, Ho T, et al. Associations between 
anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort. Breast 
Cancer Res Treat. 2014;145:545-52. 
[67] Brinton LA, Smith L, Gierach GL, Pfeiffer RM, Nyante SJ, Sherman ME, et al. Breast cancer risk in 
older women: results from the NIH-AARP Diet and Health Study. Cancer Causes Control. 2014;25:843-
57. 
[68] Boeke CE, Eliassen AH, Oh H, Spiegelman D, Willett WC, Tamimi RM. Adolescent physical 
activity in relation to breast cancer risk. Breast Cancer Res Treat. 2014;145:715-24. 
[69] Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Jr., Montoye HJ, Sallis JF, et al. Compendium of 
physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 
1993;25:71-80. 
[70] Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of 
physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32:S498-
504. 
[71] Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Jr., Tudor-Locke C, et al. 2011 
Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 
2011;43:1575-81. 
[72] Kabat GC, Kim M, Wactawski-Wende J, Lane D, Adams-Campbell LL, Gaudet M, et al. 
Recreational physical activity, anthropometric factors, and risk of ductal carcinoma in situ of the breast in 
a cohort of postmenopausal women. Cancer Causes Control. 2010;21:2173-81. 
[73] Steindorf K, Ritte R, Tjonneland A, Johnsen NF, Overvad K, Ostergaard JN, et al. Prospective study 
on physical activity and risk of in situ breast cancer. Cancer Epidemiol Biomarkers Prev. 2012;21:2209-
19. 
[74] Holli K, Isola J, Cuzick J. Hormone replacement therapy and biological aggressiveness of breast 
cancer. The Lancet. 1997;350:1704-5. 
 33 
[75] Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, et al. The decrease in 
breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670-4. 
[76] Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, et al. Relationship between 
long durations and different regimens of hormone therapy and risk of breast cancer. JAMA. 
2003;289:3254-63. 
[77] IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 91. 
&RPELQHG(VWURJHQí3URJHVWRJHQ&RQWUDFHSWLYHVDQG&RPELQHG(VWURJHQí3URJHVWRJHQ0HQRSDXVDO
Therapy. Lyon, France: World Health Organization; 2007. 
[78] Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from 
cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625-38. 
[79] Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD. Risk factors for the incidence 
of breast cancer: do they affect survival from the disease? J Clin Oncol. 2008;26:3310-6. 
[80] Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, et al. Adult weight gain and adiposity-
related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst. 
2015;107. 
[81] Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM. C-reactive protein is independently 
associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003;23:650-5. 
[82] Allin KH, Nordestgaard BG, Flyger H, Bojesen SE. Elevated pre-treatment levels of plasma C-
reactive protein are associated with poor prognosis after breast cancer: a cohort study. Breast Cancer Res. 
2011;13:R55. 
[83] Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK, et al. An inflammation-
based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow 
Inflammation Outcome Study. Br J Cancer. 2011;104:726-34. 
[84] Friedenreich CM, Neilson HK, Woolcott CG, Wang Q, Stanczyk FZ, McTiernan A, et al. 
Inflammatory marker changes in a yearlong randomized exercise intervention trial among postmenopausal 
women. Cancer Prev Res (Phila). 2012;5:98-108. 
[85] Campbell PT, Campbell KL, Wener MH, Wood BL, Potter JD, McTiernan A, et al. A yearlong 
exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc. 
2009;41:1533-9. 
[86] Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Martin BS, et al. Effect of exercise training 
on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain 
Behav Immun. 2005;19:381-8.  
Physical activity, hormone replacement therapy and breast cancer 
risk: A meta-analysis of prospective studies 
Short title: Physical activity and breast cancer risk 
Cécile Pizot 2, Mathieu Boniol 1,2, Patrick Mullie 2,3, Alice Koechlin 1,2, Magali Boniol 2, Peter 
Boyle 1,2 and Philippe Autier 1,2 
 
Figure captions 
Figure 1. Flow chart of the literature search strategy to identify cohort studies on breast 
cancer risk and physical activity. 
Figure 2. Forest plot of meta-analysis of breast cancer risk according to physical activity 
level in women. Individual studies are represented with their RR and 95% CI (highest versus 
lowest category of physical activity). The square size is proportional to the variance of the RR 
and the horizontal lines represent the corresponding 95% CI. Heterogeneity between studies 
was assessed through Q and I² statistics. Publication bias was evaluated using Begg, Egger 
and Macaskill tests. 
Figure 3. Results from stratified analyses.  
Figure 4. Dose-response relationship between breast cancer risk and physical activity in 
studies that measured physical activity in MET-h per week (A) or in hours per week (B).  
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Table S1 - Details on computation and data extraction 
First author, year Statistical computation and choice of data 
Paffenbarger, 1987 
[1] 
RR was taken from table 3 for the main analysis. As there was no 95%CI, it was computed from cases 
and PY. This study was not used in the dose-response analysis in hours/week as RRs were reported 
for dichotomous exposure (<5h/wk vs. KZN 
Dorgan, 1994 [2] RR for the main analysis was taken from the full model of table 3. 
Steenland, 1995 [3] 
This study used the same cohort as Breslow 2001 [4], hence, it was not used for the main analysis but 
for the sub analysis on occupational activity as Breslow did not report this result. RR corresponding to 
occupational activity was taken from table 5. This RR was inverted since the reference category was a 
lot of physical activity instead of little physical activity. 
Fraser, 1997 [5] RR for the main analysis was taken from table 2. As the reported RR was for low vs. High physical 
activity, the RR was inverted to have a high vs. low result. 
Thune, 1997 [6] 
Only RRs based on the survey of 1977-1983 were taken in our analysis. For the main analysis, RRs 
from table 2 were used: RR corresponding to leisure time was combined with RR corresponding to 
work using a fixed-effect meta-analysis in order to get a global measure of physical activity. For the 
stratified analysis on menopausal status, RRs from table 3 were used and a combination of leisure 
time and work was performed. For the stratified analysis on BMI, RRs corresponding to leisure 
activity was taken from table 4 (BMI<22.8 and BMI>25.7). 
Cerhan, 1998 [7] 
RR for the main analysis was taken from the full model of table 4. As the reference category was not 
the first one, we merged the first two categories and re-computed the RR for each category (from 
cases and PY). 
Sesso, 1998 [8] RR for the main analysis was taken from table 2. For the stratified analysis on menopausal status \DQG\DQG%0,DQG55VZHUHWDNHQIURPWDEOHDQGUHVSHFWLYHO\ 
Moradi, 1999 [9] 
For the main analysis, the most adjusted RR corresponding to the census of 1970 was taken from table 
2. As the 95%CI was not really precise (only 2 digits were used), a new variance and 95%CI were 
computed from cases and PY reported in table 1 for the census of 1970. Then, the result was inverted 
as the reference category was high physical activity instead of low physical activity. 
Luoto, 2000 [10] 
The most adjusted RRs from table 2 were used for the main analysis: RRs corresponding to physical 
activity at leisure and to physical activity when commuting to work were combined using a fixed-
effect meta-analysis in order to get a global non-occupational physical activity exposure. For the sub 
DQDO\VHVRQ%0,%0,DQG%0,!DQGPHQRSDXVDOVWDWXV\DQG\55VIURPWDEOe 3 
were used and as for the main analysis, RRs for leisure time and commuting to work were combined.  
Wyrwich, 2000 
[11] 
For the main analysis, RR was taken from table 1. As the reference category was not the first one 
reported, we merged the first two categories and recomputed RR for the other categories. As the 
women were aged between 70-98y at baseline, they were considered as post-menopausal women. 
Wyshak, 2000 [12] For the main analysis, the most adjusted RR was taken from table 3. 
Moore, 2000 [13] 
This study used the same cohort as Bardia 2006 [14], hence, it was not used for the main analysis but 
for the sub analyses on BMI and HRT as Bardia did not report these results. RRs for the stratified 
analysis on BMI and on HRT use were taken from table 3. For the BMI, RRs corresponding to 
quartile 1 and 4 were taken into account. For HRT use, RRs corresponding to past and current users 
were combined using a fixed-effect meta-analysis in order to get an ever users group. As only post-
menopausal women were included in the study, estrogen use was considered as HRT use. 
Breslow et al. 2001 
[4] 
RRs for the main analysis and for the stratified analyses on menopausal status were taken from table 
1. Menopausal status was defined with an age cutoff of 50y. Stratified analysis on BMI was 
performed on data from table 2 (including post-menopausal women only). 
Dirx, 2001 [15] 
RR for the main analysis was computed from total recreational activity (table 3) and energy 
expenditure from longest held job (occupational activity from table 4) using a fixed-effect meta-
analysis in order to get a global measure of physical activity. For the sub analysis on h/week, only 
recreational activity result was used as occupational activity was expressed in kJ/min. For the sub 
analysis on BMI, data from table 6 and recreational activity were used (BMI<25 vs. BMI>30). 
Lee, 2001 [16] The most adjusted RRs from table 2 was taken for the main analysis, the post-menopausal analysis 
and ER+/PR+ analysis. 
 3 
First author, year Statistical computation and choice of data 
Moradi, 2002 [17] 
RRs reported in table 2 were taken for the main analysis: leisure time RR and occupation RR were 
combined using a fixed-effect meta-analysis in order to get a global measure of physical activity. For 
the stratified analysis on menopausal status, women born in 1901-1917 were considered post-
menopausal and women born in 1918-1925 were considered pre-menopausal. RRs for the latter 
analysis were taken from table 2, leisure time RR and occupation RR were also combined. For the 
stratified analysis on BMI, RRs corresponding to leisure activity were taken from table 3: RRs for 
BMI at baseline (42-70y) in quartile I (BMI<22) and quartile IV (BMI>26.4) were used. 
Rintale, 2002 [18] 
For the main analysis, the most adjusted RRs were taken from table 2: as the results were stratified by 
age group, a fixed-effect meta-analysis was used to combine the three RRs (25-39y, 40-54y and 
\)RUWKHSUH-menopausal analysis, RRs from the age groups 25-39y and 40-54y were combined. 
For the post-PHQRSDXVDODQDO\VLVWKH55RIWKHDJHJURXS\ZDVFRQVLGHUHG 
Mc Tiernan, 2003 
[19] 
This study used the same cohort as Phipps 2011 [20], hence, it was not used for the main analysis but 
for the sub DQDO\VHVRQ%0,DV3KLSSVGLGQRWUHSRUWWKLVUHVXOW55VFRUUHVSRQGLQJWR%0,DQG
BMI>28.44 were taken from table 3. 
Patel, 2003 [21] 
This study used the same cohort as Hildebrand 2013 [22], hence, it was not used for the main analysis 
but for the sub analyses on BMI and HRT as Hildebrand did not report these results. RRs were taken 
from table 5. As the reference category was not the first one reported, we merged the first two 
categories and recomputed RR for the other categories (from cases and PY). For the BMI analysis, 
55VIRU%0,DQG%0,ZHUHXVHG)RUWKH+57DQDO\VLV55VIRUFXUUHQWDQGIRUPHUXVHUV
were combined in order to create an ever users group comparable to the never users group. 
Rintala, 2003 [23] RR for the main analysis was taken from the abstract. For the stratified analysis on menopausal status, RRs from table 2 were used (pre-menopause :<50y and post-PHQRSDXVH\ 
Margolis, 2005 
[24] 
For the main analysis, the most adjusted RR corresponding to physical activity at enrollment was 
extracted from table 2. For the stratified analysis on menopausal status, RR were extracted from the 
text. 
Schnohr, 2005 [25] The most adjusted RR from table 2 was used for the main analysis. 
Bardia, 2006 [14] The most adjusted RR from table 2 was used for the main analysis and for the stratified analysis on hormone receptor status (ER+/PR+ and ER-/PR-). 
Chang, 2006 [26] The most adjusted RR from table 2 was used for the main analysis. 
Mertens, 2006 [27] 
The most adjusted RRs from table 3 were taken for the main analysis: RRs corresponding to leisure, 
work and sport were combined using a fixed-effect meta-analysis in order to get a global physical 
activity exposure. For the post-menopausal analysis, RRs were taken from table 4 and a combination 
of leisure, work and sport activity was also performed. For the occupational physical activity analysis, 
RR corresponding to work activity was taken from table 3. Concerning non-occupational physical 
activity, RRs for leisure and sport were taken from table 3 and were combined. 
Silvera, 2006 [28] 
For the main analysis, the most adjusted RR corresponding to vigorous physical activity (in min/day) 
was taken from table 2. RRs for pre-menopausal and post-menopausal women were taken from table 
3. For the stratified analysis on BMI, RRs were computed from cases and PY (reported in table 5) for 
ZRPHQZLWKD%0,DQGZRPHQZLWKD%0, 
Tehard, 2006 [29] 
For the main analysis, the most adjusted RR corresponding to total physical activity was taken from 
table 3. For the stratified analysis on BMI, RR FRUUHVSRQGLQJWR%0,ZDVWDNHQIURPWDEOH$V
RR for BMI<25 was not reported, it was computed form cases and PY. For the sub analysis on HRT 
use, RR for HRT users was taken from table 4. As RR for HRT non-users was not reported, it was 
computed from cases and PY. For the sub analysis on h/wk, RR corresponding to vigorous 
recreational activity was taken from table 3: the two first categories of PA were combined and RRs 
were recomputed using cases and PY as the two first categories of PA correspond to inactivity. 
Dallal, 2007 [30] 
In our main analysis, we took the most adjusted RR from table 2 corresponding to strenuous physical 
activity. For the stratified analysis on menopausal status (defined with a cutoff of 55y) and BMI (<25 
YVZHXVHGGDWDIURPWDEOHEDVHGRn lifetime strenuous physical activity. In the stratified 
analysis on ER/PR status, we used data from table 5 based on strenuous activity only (ER+/PR+ and 
ER-/PR-). For the stratified analysis with studies reporting physical activity in h/week, we only used 
the RR corresponding to strenuous lifetime activity from table 2. 
Leitzmann, 2008 
[31] 
The most adjusted RR from table 2 was taken for the main analysis. For the sub analysis on BMI, RR 
FRUUHVSRQGLQJWRWRWDOSK\VLFDODFWLYLW\ZDVH[WUDFWHGIURPWDEOH%0,DQG%0,)RUWKH
sub analysis on hormone receptor status, RRs corresponding to ER+/PR+ and ER-/PR- were used. The 
latter RRs were based on vigorous physical activity and not total physical activity. 
 4 
First author, year Statistical computation and choice of data 
Maruti, 2008 [32] 
This study used the same cohort as Boeke 2014 [33], hence, it was not used for the main analysis but 
for the sub-analyses on hours/week, BMI, and hormone receptor status. For the hours/week analysis, 
RR corresponding to strenuous activity was extracted from table 2. For the sub analysis on BMI, RR 
was extracted from table 5 (BMI<DQG%0,)RUWKHsub analysis on hormone receptor status, 
results corresponding to ER+/PR+ and ER-/PR- were taken from the text. This study was also used for 
the dose-response analysis in MET-h/week instead of Boeke 2014 [33]. 
Suzuki, 2008 [34] 
For the main analysis, the most adjusted RRs were taken from table 2: RR corresponding to time spent 
walking and RR corresponding to time spent exercising were combined using a fixed-effect meta-
analysis in order to get a global physical activity exposure. The same RR was used for the sub analysis 
RQKRXUVZHHN)RUWKHVWUDWLILHGDQDO\VHVRQPHQRSDXVDOVWDWXVDQG%0,DQG55VZHUH
taken from table 5 (most active women compared to the rest of the women). 
Howard, 2009 [35] 
The most adjusted RR corresponding to total MET-score (from table 2) was taken for the main 
analysis. For the post-menopausal analysis, as the results were stratified on HRT use, RR for HRT 
ever users and RR for HRT never users were combined with a fixed-effect meta-analysis. For the sub 
analysis on hours/week, the most adjusted RR but without adjustment for other physical activities (to 
avoid colinearity) was taken from table 2. 
Peters, 2009 [36] 
This study used the same cohort as Brinton 2014 [37], hence, it was not used for the main analysis but 
for the sub-analyses on BMI, HRT and hormone receptor status. For the stratified analysis on 
hormone receptor status, RRs were taken from table 3 (ER+/PR+ vs. ER-/PR-). For the stratified 
DQDO\VLVRQ+57XVHHYHUXVHYVQHYHUXVHDQG%0,YV55VZHUHWDNHQIURP table 4. 
Peters, 2009 [38] 
This study used the same cohort as Brinton 2014 [37], hence, it was not used for the main analysis but 
for the sub-analyses on the h/week and non-occupational activity. RR corresponding to the past 10y 
and to invasive breast cancers was taken from table 7.  
George, 2010 [39] 
This study used the same cohort as Brinton 2014 [37], hence, it was not used for the main analysis but 
for the sub-analysis on occupational activity. RR corresponding to occupational and household 
activity was taken from table 3. 
Eliassen, 2010 [40] For the main analysis, RR for baseline total physical activity was taken from table 2. For the stratified 
analysis on hormone receptor status, RRs for ER+/PR+ and ER-/PR- tumors were taken from the text. 
Pronk, 2011 [41] 
RRs for the main analysis came from table 2 (non-occupational activity) and 3 (occupational activity): 
the most adjusted RRs corresponding to all non-occupational activity and to cumulative energy 
expenditure were combined using a fixed-effect meta-analysis in order to get a global physical activity 
exposure. For the stratified analysis on menopausal status, RR for post-menopausal women was 
extracted from figure 1 whereas RR for pre-menopausal women was taken from the text (>8MET-
h/wk vs. <8MET-h/wk). For the MET-h/week analysis, only non-occupational physical activity was 
taken into account as occupational activity was not reported in this unit. For the stratified analysis on 
%0,55VZHUHWDNHQIURPWKHWH[W%0,YV%0, 
Phipps, 2011 [20] 
This study was taken instead of McTiernan 2003 [19] for the main analysis as it was more recent. RRs 
from table 4 corresponding to total recreational physical activity were used. As the results were 
reported separately for ER+ and triple-negative breast cancers, we combined the both using a fixed-
effect meta-analysis in order to get a global result. For the sub analysis on hormone receptor status, we 
used ER+ as a proxy of ER+/PR+ and triple-negative as a proxy of ER-/PR-. McTiernan 2003 [19] 
was only used for the sub analysis on BMI. 
Suzuki, 2011 [42] 
For the main analysis, the stratified analysis on menopausal status and the stratified analysis on 
hormone receptor status (ER+/PR+ and ER-/PR-), the most adjusted RRs corresponding to daily total 
physical activity were taken from table 3. For the sub analysis on non-occupational activity, the most 
adjusted RR corresponding to leisure-time activity was taken from table 2. For the stratified analysis 
on BMI, RRs corresponding to leisure-WLPHDFWLYLW\ZHUHWDNHQIURPWDEOH%0,DQG%0, 
Steindorf, 2013 
[43] 
For the main analysis, RR corresponding to total physical activity was taken from table 3. For the 
stratified analysis on menopausal status, RRs from table 3 were used (pre-PHQRSDXVH\DQGSRVW-
menopause: >50y). For the sub analysis on occupational activity, RR was taken from table 3. For the 
sub analysis on non-occupational activity and MET-h/week, RRs corresponding to combined 
recreational and household activities was taken from table 3. For the stratified analysis on hormone 
receptor status, RRs corresponding to total physical activity and to ER+/PR+ and ER-/PR- were taken 
from table 4. For the stratified analysis on BMI, RRs corresponding to total physical activity were 
taken from supplementary table S1 (normal: BMI<25) and S3 (obese: BMI>30). 
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First author, year Statistical computation and choice of data 
Hildebrand, 2013 
[22] 
This study was taken instead of Patel 2003 [21] for the main analysis as it was more recent. The most 
adjusted RR from table 2 corresponding to total recreational physical activity was taken for the main 
analysis. As the reference category was not the first one reported, we merged the first two categories 
and recomputed RR for the other categories. The study of Patel was kept for the sub analyses on BMI 
and HRT.  
Hastert, 2013 [44] For the main analysis, the most adjusted RR was taken from table 3. As this RR was adjusted for the body fatness recommendation, it was considered as adjusted for BMI. 
Rosenberg, 2014 
[45] 
For the main analysis and for the stratified analysis on ER+/PR+ (ER+ was used as a proxy of 
ER+/PR+), RRs were taken from table 2. For the ER-/PR- sub-analysis, we considered triple negative 
breast cancer as a proxy of ER-/PR- and took the RR reported in the text. For the sub-analyses on 
%0,YVDQGPHQRSDXVDOVWDWXV55VZHUHWDNHQIURPWDEOH,QWKHPHWKRGVLWZDVVDLG
that all RRs were adjusted for BMI but in the footnotes of tables 2 and 4, RRs were not adjusted for 
BMI hence we considered that the RRs were not adjusted for BMI. For the sub-analysis on MET-
h/wk, RR corresponding to vigorous exercise and brisk walking was taken from the text. Nevertheless, 
this study was not used in the dose-response analysis in MET-h/wk as only a high vs. low result was 
reported in this unit. 
Borch, 2014 [46] 
This study was based on a Norwegian cohort that was included in the study of Margolis 2005, hence, 
it was not used for the main analysis but for the stratified analysis on hormone receptor status 
(ER+/PR+ vs. ER-/PR-). RRs corresponding to PA at enrollment were taken from table 4. As the RRs 
were reported considering the intermediate category of PA as reference, we recomputed the RR using 
a basic cross product and assuming the first category of PA as reference. The variance and 95%CI 
were computed from cases and PY.  
Catsburg, 2014 
[47] 
For the main analysis and for the stratified analysis on menopausal status, RRs corresponding to total 
hours per week were taken from table 3. For the sub-DQDO\VHVRQ%0,YVDQG+57XVH
(never vs. ever), RRs corresponding to total hours per week were taken from supplementary tables 2 
and 3 respectively. For the main analysis and all sub-analyses (except MET-h/wk analysis), we took 
into account the RRs corresponding to total hours per week as the total MET hours were computed 
from the hours/wk and CIs were smaller with hours/wk. 
Brinton, 2014 [37] For the main analysis, RR corresponding to physical activity in the past year was taken from table 2. 
Boeke, 2014 [33] 
For the main analysis, RR corresponding to lifetime physical activity was taken from the text. For the 
stratified analyses on menopausal status, RRs were taken from table 2. As the RRs were reported 
separately for each adolescent period, we combined all periods with a fixed-effect meta-analysis using 
the less adjusted RR (the most adjusted RR was adjusted for adult physical activity hence this result is 
prone to colinearity). This study was not used for the dose-response analysis in MET-h/wk as only a 
high vs. low result corresponding to lifetime physical activity was reported in the text. We preferably 
used Maruti 2008 [32]data for this dose-response analysis.  
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Table S2 - Duplicate studies that were excluded from main analysis 
Study Reason for exclusion 
Frisch, 1987 [48] Same cohort as Wyshak, 2000 [12]. 
Albanes, 1989 [49] Same cohort as Breslow 2001 [4]. 
Vihko, 1992 [50] Same cohort as Rintala, 2003 [23]. 
Pukkala, 1993 [51] Same cohort as Rintala, 2003 [23]. 
Steenland, 1995 [3] Same cohort as Breslow, 2001 [4]; Steenland, 1995 [3] was only used for the sub-analysis on 
occupational activity.  
Byrne, 1996 [52] Same cohort as Breslow, 2001 [4]. 
Rockhill, 1998 [53] Same cohort as Boeke, 2014 [33]. 
Rockhill, 1999 [54] Same cohort as Eliassen, 2010 [40]. 
Moore, 2000 [13] Same cohort as Bardia, 2006 [14]; Moore, 2000 [13] was only used for the stratified analyses on BMI and HRT use.  
McTiernan, 2003 [19] Same cohort as Phipps, 2011 [20]; Mc Tiernan 2003 [19] was only used for the stratified analysis 
on BMI. 
Colditz, 2003 [55] Same cohort as Boeke, 2014 [33]. 
Patel, 2003 [21] Same cohort as Hildebrand 2013 [22]; Patel 2003[21] was only used for the stratified analyses on BMI and HRT use. 
Lahmann, 2007 [56] Same cohort as Steindorf 2013 [43]. 
Ji, 2008 [57] Same cohort as Pronk 2011 [41]. 
Inoue, 2008 [58] Same cohort as Suzuki 2011 [42]. 
Maruti, 2008 [32] Same cohort as Boeke 2014 [33]; Maruti 2008 [32] was only used for the stratified analyses on hours/week, BMI, and hormone receptor status.  
Peters, 2009 [38] Same cohort as Brinton 2014 [37]; Peters 2009 [38] was only used for the stratified analyses on hours/week and non-occupational physical activity. 
Peters, 2009 [36] Same cohort as Brinton 2014 [37]; Peters 2009 [36] was only used for the stratified analyses on BMI, hormone receptor status and HRT use. 
George, 2010 [39] Same cohort as Brinton 2014 [37]; Peters 2009 [38] was only used for the stratified analysis on 
occupational physical activity. 
Fournier, 2014 [59] Same cohort as Tehard 2006 [29]; they used recent physical activity (previous four years) instead of baseline physical activity which might imply reverse causation. 
McKenzie, 2014 [60] Same cohort as Steindorf 2013 [43] but they used a smaller sample size and smaller follow-up. Moreover, they focused on healthy lifestyle index and not precisely on physical activity. 
Borch, 2014 [46] This study was based on a Norwegian cohort that was included in the study of Margolis 2005 [24], hence, it was only used for the stratified analysis on hormone receptor status. 
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Table S3 - Breast cancer types included in prospective studies 
First author, year Type of cancer considered in results Invasive 
only a 
Paffenbarger, 1987 [1] No information about the type of breast cancer (invasive or in-situ or both). N 
Dorgan, 1994 [2] No information about the type of breast cancer (invasive or in-situ or both). N 
Steenland, 1995 [3] No information about the type of breast cancer (invasive or in-situ or both). N 
Fraser, 1997 [5] RRs reported for invasive breast cancer only. Y 
Thune, 1997 [6] RRs reported for invasive breast cancer only. Y 
Cerhan, 1998 [7] RR reported for all, localized, and regional/disseminated breast cancers. We only used the result for all cancers. Y 
Sesso, 1998 [8] No information about the type of breast cancer (invasive or in-situ or both). N 
Moradi, 1999 [9] RRs reported for invasive breast cancer only. Y 
Luoto, 2000 [10] No information about the type of breast cancer (invasive or in-situ or both). N 
Wyrwich, 2000 [11] RR reported for all, localized, and regional/distant breast cancers. We only used the result for all cancers. Y 
Wyshak, 2000 [12] No information about the type of breast cancer (invasive or in-situ or both). N 
Moore, 2000 [13] No information about the type of breast cancer (invasive or in-situ or both) but Bardia 2006 [14] used the same cohort and included both invasive and in-situ breast cancers. N 
Breslow, 2001 [4] No information about the type of breast cancer (invasive or in-situ or both). N 
Dirx, 2001 [15] Results on invasive breast cancers only as the in-situ breast cancers were excluded from the study. Y 
Lee, 2001 [16] 322 invasive and 79 in-situ breast cancers were included in this study. Results were reported for all cancers only. N 
Moradi, 2002 [17] No information about the type of breast cancer (invasive or in-situ or both). N 
Rintala, 2002 [18] No information about the type of breast cancer (invasive or in-situ or both). N 
McTiernan, 2003 [19] This study included 85% of invasive breast cancers and 15% of in-situ breast cancers. Reported RRs were for all cancers 
combined. N 
Patel, 2003 [21] This study included in-situ, localized and regional/distant breast cancers but for the sub analyses on BMI and HRT only RRs for all cancers were reported. Y 
Rintala, 2003 [23] No information about the type of breast cancer (invasive or in-situ or both). N 
Margolis, 2005 [24] RRs reported for invasive breast cancers only. Y 
Schnohr, 2005 [25] No information about the type of breast cancer (invasive or in-situ or both). N 
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First author, year Type of cancer considered in results Invasive 
only a 
Bardia, 2006 [14] Results reported for both invasive and in-situ breast cancers combined.  N 
Chang, 2006 [26] Results reported on all cases but there were 13% of in-situ breast cancers and 27% of non-confirmed breast cancers. Authors 
said that the results with the exclusion of in-situ and non-confirmed cases did not differ from the results for all cases. N 
Mertens, 2006 [27] No information about the type of breast cancer (invasive or in-situ or both). N 
Silvera, 2006 [28] No information about the type of breast cancer (invasive or in-situ or both). N 
Tehard, 2006 [29] RRs reported for invasive breast cancers only as in-situ breast cancers were excluded. Y 
Dallal, 2007 [30] 2,649 invasive breast cancers and 593 in-situ breast cancers included in the study but results were reported separately for invasive and in-situ breast cancers. We only took invasive breast cancer results in our analyses. Y 
Leitzmann, 2008 [31] This study included 17% of in-situ breast cancers and reported RRs for all cancers as the results remained the same when in-
situ breast cancers were excluded. N 
Maruti, 2008 [32] RRs reported for invasive breast cancers only as in-situ and unconfirmed breast cancers were excluded. Y 
Suzuki, 2008 [34] No information about the type of breast cancer (invasive or in-situ or both). N 
Howard, 2009 [35] RRs reported for invasive breast cancers only as in-situ breast cancers were excluded. Y 
Peters, 2009 [36] 
5,433 invasive breast cancers and 1176 in-situ breast cancers included in the study but results were reported separately for 
both type of cancers. For the stratification on hormone receptor status only RRs for invasive breast cancers were reported. 
Nevertheless, for the sub analyses on BMI and HRT use, RRs were reported for all breast cancers. 
N 
Peters, 2009 [38] 3,522 invasive breast cancers and 736 in-situ breast cancers included in the analysis but results were reported separately for both type of cancers. We only considered the results for invasive breast cancers in our analyses.  Y 
George, 2010 [39] 2,866 invasive breast cancers and 570 in-situ breast cancers but results were reported separately for both type of cancers. Y 
Eliassen, 2010 [40] RRs reported for invasive breast cancers only. Y 
Pronk, 2011 [41] RRs reported for invasive breast cancers only. Y 
Phipps, 2011 [20] RRs reported for invasive breast cancers only as in-situ breast cancers were censored. Y 
Suzuki, 2011 [42] No information about the type of breast cancer (invasive or in-situ or both). N 
Steindorf, 2013 [43] RRs reported for invasive breast cancers only. Y 
Hildebrand, 2013 [22] No information about the type of breast cancer (invasive or in-situ or both) but Patel 2003 [21]used the same cohort and included invasive breast cancers defined as localized and regional/distant breast cancers. N 
Hastert, 2013 [44] RRs reported for invasive breast cancers only as in-situ breast cancers were censored. Y 
Rosenberg, 2014 [45] RRs reported for invasive breast cancers only as in-situ breast cancers were censored. Y 
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First author, year Type of cancer considered in results Invasive 
only a 
Borch, 2014 [46] RRs reported for invasive breast cancers only. Y 
Catsburg, 2014 [47] RRs reported for invasive breast cancers only. Y 
Brinton, 2014 [37] RRs reported for invasive breast cancers only as in-situ breast cancers were censored. Y 
Boeke, 2014 [33] RRs were reported for both types of breast cancer as results were similar for invasive and in situ cases. N 
a
 Y/N: Yes/No   
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Table S4 - Assessment of physical activity in prospective studies (duplicate studies from which some data were used are in light grey) 
Study Type of PA  Units used Categories Period in life for PA assessment 
  
Occupational/non-
occupational/both  
Total/Vigorous 
MET-h/ 
week a 
Hours/ 
week b 
KJ/d 
(energy 
per unit of 
time) 
Other 3+ 
categories 2 categories Baseline 
c
 During lifetime  
During 
follow-up 
(FU) 
Paffenbarger, 1987 [1] Non-occupational   y       y   Early college   
Dorgan, 1994 [2] Both PA combined       y y   y     
Steenland, 1995 [3] Occupational       y y   y     
Fraser, 1997 [5] Both PA combined       y y   y     
Thune, 1997 [6] Non-occupational       y y   y     
Thune, 1997 [6] Occupational       y y   y     
Cerhan, 1998 [7] Non-occupational       y y   y     
Sesso, 1998 [8] Non-occupational     y   y   y     
Moradi, 1999 [9] Occupational       y y     
Adult life (1960 
and 1970 
censuses) 
  
Luoto, 2000 [10] Non-occupational       y y   y     
Wyrwich, 2000 [11] Non-occupational       y y   y     
Wyshak, 2000 [12] Non-occupational       y   y   College   
Moore, 2000 [13] Non-occupational       y y   y     
Breslow, 2001 [4] Non-occupational       y y     
Long term 
(baseline + 10y 
before) 
  
Dirx, 2001 [15] Non-occupational - total PA   y     y   y     
Dirx, 2001 [15] Occupational     y   y     y   
Lee, 2001 [16] Non-occupational     y   y   y     
Moradi, 2002 [17] Non-occupational       y y     Adult (25-50 years)   
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Study Type of PA  Units used Categories Period in life for PA assessment 
  
Occupational/non-
occupational/both  
Total/Vigorous 
MET-h/ 
week a 
Hours/ 
week b 
KJ/d 
(energy 
per unit of 
time) 
Other 3+ 
categories 2 categories Baseline 
c
 During lifetime  
During 
follow-up 
(FU) 
Moradi, 2002 [17] Occupational       y y         
Rintala, 2002 [18] Occupational       y y     Baseline, at age 20 and at age 35   
McTiernan, 2003 [19] Non-occupational y       y   y     
Patel, 2003 [21] Non-occupational y       y   y     
Rintala, 2003 [23] Occupational       y   y   y   
Margolis, 2005 [24] Non-occupational       y y   y     
Schnohr, 2005 [25] Non-occupational       y y   y     
Bardia, 2006 [14] Non-occupational       y y   y     
Chang, 2006 [26] Non-occupational - 
vigorous PA   y     y   y     
Mertens, 2006 [27] Non-occupational       y y   y     
Mertens, 2006 [27] Occupational       y y   y     
Silvera, 2006 [28] Non-occupational - 
vigorous PA   y     y   y     
Tehard, 2006 [29] Non-occupational - total PA y       y   y     
Tehard, 2006 [29] Non-occupational - 
vigorous PA   y     y   y     
Dallal, 2007 [30] Non-occupational - 
strenuous PA   y     y     
Between high 
school and curent 
age 
  
Leitzmann, 2008 [31] Both PA combined - total PA y       y   y     
Maruti, 2008 [32] Non-occupational - total PA y       y     
Adolescence and 
adult (from age 12 
to current age) 
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Study Type of PA  Units used Categories Period in life for PA assessment 
  
Occupational/non-
occupational/both  
Total/Vigorous 
MET-h/ 
week a 
Hours/ 
week b 
KJ/d 
(energy 
per unit of 
time) 
Other 3+ 
categories 2 categories Baseline 
c
 During lifetime  
During 
follow-up 
(FU) 
Maruti, 2008 [32] Non-occupational - 
strenuous PA   y     y     
Adolescence and 
adult (from age 12 
to current age) 
  
Suzuki, 2008 [34] Both PA combined   y     y   y     
Howard, 2009 [35] Both PA combined - total PA y       y   y     
Howard, 2009 [35] Both PA combined - 
strenuous PA   y     y   y     
Peters, 2009 [36] Both PA combined       y y   y     
Peters, 2009 [38] Non-occupational - 
moderate/vigorous PA   y     y     Past 10y   
George, 2010 [39] Occupational       y y   y     
Eliassen, 2010 [40] Non-occupational y       y      
Baseline (past 
year) + updtate 
every 2 or 4 
years 
Pronk, 2011 [41] Non-occupational - total PA y       y     
Baseline + 5 years 
before interview   
Pronk, 2011 [41] Occupational     y   y     y   
Phipps, 2011 [20] Non-occupational - total PA y       y   y     
Suzuki, 2011 [42] Non-occupational       y y       
Baseline + 
update 5 years 
after 
Suzuki, 2011 [42] Both PA combined - total PA y       y         
Steindorf, 2013 [43] Non-occupational y       y   y     
Steindorf, 2013 [43] Occupational       y y   y     
Steindorf, 2013 [43] Both - total PA       y     y     
 13 
Study Type of PA  Units used Categories Period in life for PA assessment 
  
Occupational/non-
occupational/both  
Total/Vigorous 
MET-h/ 
week a 
Hours/ 
week b 
KJ/d 
(energy 
per unit of 
time) 
Other 3+ 
categories 2 categories Baseline 
c
 During lifetime  
During 
follow-up 
(FU) 
Hildebrand, 2013 [22] Non-occupational - total PA y       y      
Baseline + 
updated 3 
times during 
FU 
Hastert, 2013 [44] Non-occupational       y   y   Past 10y   
Rosenberg, 2014 [45] Non-occupational - 
vigorous PA   y     y   y     
Borch, 2014 [46] Both PA combined       y y   y     
Catsburg, 2014 [47] Non-occupational - total PA y y     y   y     
Brinton, 2014 [37] Both PA combined       y y   y     
Boeke, 2014 [33] Non-occupational - total PA y       y     
Adolescence and 
adult (from age 12 
to current age) 
  
a
 14 articles reported MET-h/week but 11 were not duplicate studies. 
b
 12 articles reported hours/week but 11 classified in 3 categories or more. 
c
 Usually, physical activity during the year preceding cohort inception. 
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